Tag: Health

Pune (Maharashtra) [India], June 28: Dental Tree, founded by Dr. Athira and Dr. Ganesh, stands as a beacon of personalized patient care with a state-of-the-art dental clinic setting. Dr. Ganesh is a highly experienced Prosthodontist and Implantologist committed to providing top-tier dental care using the latest in dental technology and advanced techniques.

As alumnae of the esteemed Government Dental College in Kozhikode, Kerala, Dr. Athira and Dr. Ganesh have dedicated their careers to advancing the field of dentistry. Their expertise and innovative approach have propelled Dental Tree to become one of the leading dental hospitals in Pune, known for its exceptional patient care and cutting-edge treatments.

Their commitment to excellence is further exemplified by their extensive academic achievements.

One of the standout features of Dental Tree is its groundbreaking approach to dental implantation. Traditional dental implant procedures typically involve a waiting period of three to six months before a crown can be placed on an implant. However, Dr. Ganesh offers a remarkable alternative: fixed teeth placement within just three days that too with use of conventional implants. Use of conventional implants in conjunction with advanced technology, helps to significantly reduce the treatment time and enhanced patient convenience.

Dr. Ganesh explains, “Our advanced techniques and technology allow us to provide immediate solutions for our patients, ensuring they can enjoy their new teeth without the prolonged waiting period”.

Dentaltree stands out as a distinguished dental clinic specializing in immediate loading implant procedures _ a ground breaking approach in the field of dentistry. With a stellar reputation for delivering exceptional results. Dentaltree has become a trailblazer in providing swift and efficient tooth replacement solutions. Immediate loading implants also known as same day Implants, involve the placement of dental implants and the attachment of a prosthetic restoration in a single visit.

Apart from new-age implant solutions, Dental Tree also provides comprehensive dental services like porcelain laminate veneers, full mouth rehabilitation, and single sitting root canals that promise quick smile corrections that last long.

In Dentaltree, with advanced smile makeover countless patients experienced dramatic improvement in their smile. Dr. Athira and Dr. Ganesh is well known for their transparent and honest approach to their patients in providing best dental solutions that is cost effective and long lasting.

Dr. Athira and Dr. Ganesh’s dedication to patient care is evident in every aspect of Dental Tree. From the initial consultation to the final follow-up, the team at Dental Tree prioritizes patient comfort and satisfaction. They believe in a holistic approach to dental care, where education and communication play vital roles in empowering patients to maintain optimal oral health.

Ranked among the best dentists in Pune, Dental Tree focuses on delivering exceptional dental care that consistently exceeds patient expectations. The clinic has earned a reputation for excellence, largely due to the relentless pursuit of innovation and a patient-centric approach by its founders.

Dr. Athira and Dr. Ganesh continually upgrade their skills and techniques, keeping pace with the latest advancements in dental care. This dedication to professional development ensures that Dental Tree remains at the forefront of the dental industry, providing patients with the highest standard of care.

For more information about Dental Tree and its services, visit their website at dentaltree.in or call 8669589999 / 020-25889999. Experience the difference in dental care at Dental Tree, where your smile and health are our top priorities.

Follow Dental Tree on social media:

Facebook: https://www.facebook.com/dentaltreepune/  

Instagram: https://www.instagram.com/dentaltree_dental_clinic_

Youtube: https://www.youtube.com/@DentalTree For media inquiries, please contact:

Dr. Athira & Dr. Ganesh 8669589999 / 020-25889999

https://dentaltree.in

FAQs

Q: How long does it take to get dental implants at Dental Tree?

A: Unlike traditional methods, Dental Tree offers fixed teeth placement within just 3 days, thanks to its advanced technology and expertise. This rapid service allows patients to enjoy their new teeth without the lengthy waiting periods typically associated with dental implants.

Q: Where did Dr. Athira and Dr. Ganesh complete their education?

A: Both Dr. Athira and Dr. Ganesh are proud alumni of the prestigious Government Dental College in Kozhikode, Kerala. Their extensive education and training at this renowned institution underpin their expert care and innovative approach to dentistry.

Q: What services does Dental Tree offer?

A. Dental Tree offers a comprehensive range of dental services to address various oral health needs. These include single-sitting root canals, which minimize patient discomfort and time, and porcelain laminate veneers for quick and durable smile corrections. Full mouth rehabilitations, surgical removal of wisdom teeth, orthodontic treatments. Additionally, the clinic provides preventive and cosmetic dentistry, routine check-ups, cleanings, teeth whitening, and specialized pediatric dentistry.

Q: What sets Dental Tree apart from other dental clinics?

A: Dental Tree is distinguished by its advanced technology, expertise in dental implants, and unwavering commitment to patient comfort and satisfaction. The clinic’s innovative approach to dental care, use of sophisticated world class equipment and absolute adherence to global standers for clinical hygiene and safety as set by the Indian Dental association, the American Dental Association and the U.S food aane Drug administration. Furthermore, the personalized care provided by Dr. Athira and Dr. Ganesh ensures that every patient receives the highest standard of treatment tailored to their individual needs.

About Dental Tree:

Dental Tree, founded by Dr. Athira and Dr. Ganesh, is a leading dental clinic in Aundh, Pune, specializing in implantology and smile designing. Committed to providing the best possible dental care, Dental Tree is your destination for a healthy, beautiful smile.

If you have any objection to this press release content, kindly contact pr.error.rectification@gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.

New Delhi (India), June 27: Dr Batra’s® Healthcare, the world’s largest chain of homeopathic clinics, introduces a pioneering innovation with the launch of XOGEN, an exosome-based targeted hair treatment designed for men and women, to revolutionize the management of hereditary hair loss with its exosome-based formulation.

XOGEN represents a cutting-edge advancement in hair restoration, using a potent formula of 2 billion cells to regenerate hair. Clinically proven to show visible results in just three months. It stimulates stem cells for natural regrowth, nourishes follicles, reduces scalp inflammation and enhances blood flow for stronger, thicker hair. The process involves releasing growth factor-rich exosomes onto the scalp, which then migrate and latch onto damaged hair cells, deeply absorbing and delivering essential nutrients to promote repair and healing.

Commenting on the launch Dr. Akshay Batra, Vice-Chairman and Managing Director of Dr Batra’s® Healthcare and the first Indian President of the Trichological Society of London (UK) said, “We are thrilled to introduce XOGEN, the world’s most advanced exosome-based hair treatment. This targeted therapy and regeneration medicine accelerates hair growth and revitalizes hair follicles. XOGEN is the fastest treatment which gives best results even to those suffering from hereditary hair loss. At Dr Batra’s®, we are committed to providing the best possible treatments and ensuring our patients’ satisfaction.”

XOGEN treatment option will be available at all Dr Batra’s® clinics across India and Dubai, backed by a money-back guarantee*. For more information about XOGEN and to book a consultation, visit www.drbatras.com or contact our nearest clinic.

About Dr Batra’s®

With over 200+ clinics in around 160 cities across five countries, including India, Bangladesh, the UK, UAE, and Bahrain, Dr Batra’s® Homeopathy Clinics has over 350 doctors, including skin specialists, hair specialists and experienced homeopathic doctors. Dr Batra’s ® has treated over 1 million patients and has been recognized as an ‘Icon of Indigenous Excellence in Healthcare’ by The Economic Times. Dr Batra’s ® specializes in Hair, Skin, Allergies, Child and Women’s Health, Mental Health, Sexual Health and Weight Management ailments, including Hair loss, Vitiligo, Psoriasis, Acne, Low immunity, Tonsillitis, Stress Management, Migraine, Thyroid, PCOS, Menopause, Allergies, Sexual Health, Weight Management, Infertility and Male Infertility.

For more information:

Website: www.drbatras.com

If you have any objection to this press release content, kindly contact pr.error.rectification@gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.

New Delhi (India), June 24: Human Diagnostics GmbH, Wiesbaden, Germany, a global player in the in vitro diagnostics industry, offering a broad portfolio of high quality made in Germany products to over 160 countries for over 50 years, and Medsource Ozone Biomedicals, one of the largest Indian IVD manufacturers, today announced the setting up of Human Diagnostics India (P) Ltd under a joint venture agreement between the two organizations.

Aligning with the Government of India initiative of ‘Make in India’, Human Diagnostics India is committed to offer world class clinical diagnostics products to the Indian market. As a part of long-standing association, Medsource Ozone Biomedicals has already begun the manufacture of Autoimmune diagnostic kits in India jointly with Human Diagnostics GmbH since past one year. The new initiative is aimed at enabling a much wider adoption and a deeper collaboration with Indian healthcare industry. Cutting edge clinical diagnostic platforms being introduced by Human will be channelled through the new joint venture company. Additionally, the plan is to bring German manufacturing and technologies to be adapted for Indian markets, making products affordable while maintaining German standards at all times. There is also potential for products being made in India to be taken to global markets through this JV.

Dr. Bjorn Breth, Managing Director, Human Diagnostics GmbH, Germany expressed his happiness and spoke on the potential of this Indo-German collaboration, “We are amazed with the potential that India presents. We are in this market for over 20 years and are glad to see the progress of the country, and the positive impact our products have created in healthcare space in developing economies. Dr. Arvinder Singh, Director, Human India (P) Ltd, said that we are excited on the road ahead for Human India Diagnostics – several new opportunities exist, and we can support our existing partners like never before. We shall bring together German technology and Indian manufacturing ecosystem for innovative, never thought before solutions in healthcare.”  

Mr. Ajaykumar Bhatt, CEO, Medsource Ozone Biomedicals, said “It gives us an immense pleasure to be a part of this joint venture and see tremendous potential of this partnership. Human India will serve the need for reliable, accurate and high-quality products for all stakeholders and partners of Human Diagnostics in India, not just Medsource Ozone. As one of India’s leading IVD manufacturer, we are excited to take this collaboration forward serving Indian as well as global markets in the coming times. We are already looking at several potential projects in molecular diagnostics, autoimmunity, conventional lab diagnostics, point of care testing and even new automation options through this JV.”  

About Medsource Ozone

Medsource Ozone Biomedicals is one of the largest Indian diagnostics products (IVD) manufacturer. Founded in 2003, the Delhi NCR based organization provide comprehensive solutions for medium and large sized labs across India and 40 global countries for clinical chemistry, hematology, rapid diagnostic tests, molecular diagnostics, immunohematology, immunoassays, diabetes monitoring, blood banking and autoimmune diagnostics. Being one of the largest rapid test manufacturers, Medsource Ozone offers one of the largest range of in vitro diagnostic product range from their 3 manufacturing facilities including a new upcoming plant at Delhi NCR. The complete range of products are offered to customers through a team of professional sales, application and service team and qualified distribution partners.

About Human GmbH Diagnostics, Germany

For 50 years HUMAN has been serving the healthcare sector. HUMAN’s success is based on three pillars: A broad and constantly growing portfolio of in vitro diagnostic products with quality made in Germany, outstanding worldwide available service, support and supply capabilities and a grown culture of partnership with our distribution partners in more than 160 countries. All together HUMAN is global player in the in vitro diagnostics industry.

If you have any objection to this press release content, kindly contact pr.error.rectification@gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.

The company unveils groundbreaking E-Smart Clinic Project in Agra

Mumbai (Maharashtra) [India], June 24: Lords Mark Industries Ltd, a leading manufacturer of IVD products, in collaboration with Unnat Bharat Abhiyan, a National Programme by the Government of India, under the initiation of FIIT (Foundation for Innovation and Technology Transfer), IIT Delhi is thrilled to announce the inauguration of the revolutionary E Smart Clinic in Anwal Khera village, Agra in Uttar Pradesh. This initiative aims to redefine healthcare accessibility across the region, marking a significant milestone in advancing healthcare infrastructure. 

Previously, the company launched the E-Smart Clinic project in Haridwar, Uttarakhand, which received an overwhelming response from the local communities. Committed to serving the nation, Lords Mark Industries endeavours to expand the reach of the E-Smart Clinic across the country by making it portable and mobile, ensuring convenience and accessibility. This initiative seeks to provide testing and consultation services to patients at a nominal cost of less than Rs. 1000. The company plans to deploy 16,000 E-Smart Clinics throughout India. The collaboration with Unnat Bharat Abhiyan and FIIT represents a leap forward in democratising healthcare technology and innovation to make a tangible difference in millions of lives across India.

The inauguration ceremony, witnessed esteemed dignitaries, alongside a host of bureaucrats and other eminent personalities include Shri Ashish Chauhan, Shri Y. P. Singh, Shri Chakra Bhushan Pandey, Shri Chunnilal from Unnat Bharat Abhiyan while others are among the local communities include ACMO – Dr. Sanjiv Barman, Dr. Vijay – Superintendent of CHC, Awalkheda, Mr. Ravinder Chauhan –  Gram Pradhan, Shri Avnish – Director RUDSETI, ADO Panchayat Shri Pankaj Yadav, Dr Vijay Kumar – Medical officer In-charge cum Superintendent, Dr Gyanada Mishra – Dentist, Dr. Manushil Pachori – Dentist, Dr. Akancha Singh – Medical Officer, Dr. Upasna Porwal – DMS (Ayurveda), Smt. Neha Verma – Staff Nurse, Shri Arjun Singh – Pharmacist, Shri Rajendra Singh – Pharmacist, Shri Sourav and Shri Harimohan – X-Ray Technician, Shri Devangan Ghanshyam – Manager, Shri Akhil Vishwa – Gayatri Pariwar, Anwalkhera, Shri Jagdish Kushwaha, Shri Akhil Vishwa – Gayatri Pariwar, Representative, Shri Dindayal – Devotee, Akhil Vishwa Gayatri Pariwar and Shri Ranjit Raghav – Social Activist, Murlidharpur.

The E Smart Clinic project is poised to bring about a paradigm shift in healthcare delivery, leveraging state-of-the-art technology and innovative solutions initiating Contactless Vital Monitoring, telemedicine, consultation and point-of-care diagnostics, the E-Smart Clinic tracks diverse parameters such as live vitals, biochemistry, hematology, infectious diseases, cardiac and inflammation, body and urine parameters and maternity. 

Commenting on the occasion, Mr. Sachidanand Upadhyay, Managing Director, Lord’s Mark Industries Ltd, “We are delighted to launch our first E Smart Clinic in Uttar Pradesh at Agra. The inauguration of E Smart Clinic underlines our commitment to revolutionise healthcare accessibility through technology intervention. We are proud to collaborate with the Government in India in its mission to make preventive healthcare accessible to all. E Smart Clinic leverages new-age technology to bring healthcare closer to local communities. The E Smart Clinic at Agra is a part of our mission to play an enabling role to build a healthier society and help people lead a healthier life.”

The E Smart Clinic, developed by Lords Mark Industries in collaboration with their technology partner Dozee, utilizes patented technology to detect vital parameters of patients without any external attachments. Capable of conducting blood tests in just 20 minutes, the clinic seamlessly connects rural patients with top doctors online, communicating in their local language. Lord’s Mark Industries has filed patents for the biochemistry and the health kiosk, boasting an accuracy level of 99 percent. This marks the first instance globally of delivering such a portable solution to patients at an exceptionally low cost for disease detection, coupled with seamless online interaction with top-tier doctors aligning with the Honourable Prime Minister’s vision of affordable medical infrastructure.

Mr. Manav Teli, Executive Director, Lord’s Mark Industries Ltd, added, “The E Smart Clinic at Agra is our second E Smart Clinic in the country and we are now on a mission to redefine the healthcare delivery with advanced technology. We would like to express our heartfelt gratitude to the authorities for their assistance in setting up the E Smart Clinic in Agra. We welcome the people of the city and adjacent areas to experience the exceptional healthcare services at the E Smart Clinic.” 

Following successful trials at five initial centres, the E Smart Clinic will be commercialized across India, with international partners expressing interest in global distribution. The market potential for the E Smart Clinic in India exceeds 3000 crores, presenting additional opportunities for Lords Mark Industries to supply consumables for various therapeutic tests. The launch of the E Smart Clinic project marks a significant milestone in the quest for accessible and affordable healthcare for all citizens, aligning with the government’s overarching vision of a healthier, more prosperous India.

About Lord’s Mark Industries:

Incorporated in 1998, Lord’s Mark Industries Ltd. (Lord’s) has made impressive growth starting from paper to LED to Renewable energy and making grand in the medical diagnostic industry. Lord’s and its subsidiaries have made a mark in Electric Vehicle, Genome Testing, Vitamin Industry and Healthcare. Growth through diversification has become the trend setter and has been the cornerstone of success at Lord’s.

Website – https://lordsmark.com/

If you have any objection to this press release content, kindly contact pr.error.rectification@gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.

Bengaluru (Karnataka) [India], June 20:  Sakra World Hospital, Bengaluru, has achieved a remarkable milestone by completing over 425 orthopedic surgeries in May. Under the expert leadership of Dr. Chandrashekar P., Director of Orthopedics, the 15-membered orthopedic team has made history by setting a new standard in the state of Karnataka. The team performed 275+ joint replacements, the highest recorded monthly, along with more than 70 arthroscopy surgeries and remaining trauma surgeries. This achievement made Sakra World Hospital the first hospital in Karnataka to reach such an impressive volume of surgeries in just 30 days.

The Institute of Orthopedics has performed more than 30,000 surgeries under his guidance and has served the community for 11 years. In reality, orthopedic surgeries pose unique challenges due to factors such as the complexity of the musculoskeletal system, variability in patient anatomy, and the need for precision in surgical techniques. Surgeons must navigate these complexities while ensuring optimal alignment, stability, and functionality of the affected area. Additionally, orthopedic procedures often involve delicate soft tissue management and intricate bone adjustments, which makes joint replacement challenging.

“We take pride in sending all these patients back home, following up with their physiotherapy, significantly improving their lifestyle, alleviating their pain, and bringing smiles to them and their families. In addition to knee replacements, we provide comprehensive 360-degree coverage, including cardiology services for our surgical patients. The majority of our knee replacement patients are geriatric and often have conditions such as diabetes, hypertension, and coronary issues. These patients require a high level of care. We have a dedicated cardiology ICU team available 24/7 to assist the Department of Orthopedics whenever needed,” shared Dr. Chandrashekar P., Director of Orthopedics. 

Among these 275+ patients, Sakra had individuals with pacemakers, angioplasty opting for knee replacements, and those who had previously undergone coronary bypass surgery. The team is equipped to cater to all sorts of patients, offering 24/7, round-the-clock facilities. Now in the 11th year of operation, Sakra utilizes navigation and robotic-assisted surgeries, as well as arthroscopy or keyhole surgeries for both the knee and shoulder. 

Arthroscopic surgeries involve ligament repairs such as ACL and PCL repairs, as well as meniscal and cartilage surgeries in the knee. For shoulder procedures, muscle repairs known as rotator cuff repairs, dislocation-related surgeries called Bankart surgeries, cartilage surgeries, and shoulder replacements are regularly performed.

“It’s a moment of immense pride for Sakra for completing over 275 joint replacement surgeries within a month is a significant achievement, given the meticulous care required for such delicate procedures,” shared Mr. Lovekesh Phasu, Group Chief Operating Officer of Sakra World Hospital, Bengaluru.

“We are delighted to reach this milestone in such a short time. Sakra is committed to bringing more developments for the betterment of our patients. With the trust of our patients, we aim to continue growing,” shared Mr. Naoya Matsumi, Deputy Managing Director of Sakra World Hospital, Bengaluru.

If you have any objection to this press release content, kindly contact pr.error.rectification@gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.

Mumbai (Maharashtra) [India], June 19: Samad Hussain Patanwala is a vibrant, visionary leader. With a solid history in pharmaceutical distribution, Samad has been important in propelling the firm to new heights of success. Den Mark Pharmaceuticals has developed rapidly under his supervision, becoming a well-known distributor in India and worldwide. With a strong emphasis on digital transformation and ongoing development, Samad is dedicated to increasing Den Mark Pharmaceuticals’ reach and contributing to customer well-being through accessible and dependable healthcare products.

THE RISE OF DEN MARK PHARMACEUTICALS UNDER CEO SAMAD HUSSAIN PATANWALA

Den Mark Pharmaceuticals began its journey as a small-scale pharmaceutical provider with only moderate premises. The firm’s most extensive services were initially just a minimal number of fields; however, it has expanded significantly since its founding under its inventive CEO Samad Hussain Patanwala. Den Mark Pharmaceuticals is now a major distributor and spreads life-saving pharmaceuticals, antibiotics, cancer A group of therapy drugs, and a wide range of tablets, capsules, syrups, and ointments to thousands of merchants around the world. It is presently steered by the current CEO Samad Hussain Patanwala; the firm continues to expand in size and ascend in its place in the market.

Den Mark Pharmaceuticals has a trademarked diversified array that incorporates a broad range of drugs for critical diseases. Since Den Mark Pharmaceuticals is an autonomously demanded pharmaceutical that can propose a diversified economic outreach from various healthcare facilities, it is well-favoured with customers. Since its humble origins, the firm has grown to become a strong player in the pharmaceutical distribution market. With a diversified product range, rigorous adherence to quality control standards, and an efficient distribution network, the firm has established itself as a top distributor in a globally competitive market.

DEN MARK PHARMACEUTICALS’ MISSION FOR GLOBAL ACCESSIBILITY

Den Mark Pharmaceuticals has gained its clients’ confidence and loyalty via its management’s constant focus, a customer-centric approach, and fortitude during difficult times. As the firm plans for global development and future growth, its dedication to adaptation and upholding the highest standards will fuel its sustained success in the pharmaceutical distribution market. While regional development creates new obstacles, Den Mark Pharmaceuticals is committed to adaptation, aiming to stay ahead of changing market dynamics and preserve its image as a trusted and promising distributor.

As Den Mark Pharmaceuticals looks to the future, management foresees further growing the company’s worldwide influence, targeting various underprivileged countries. “We intend to capitalise on rising demand in the generic market, positioning ourselves for future growth and opportunities in other states,” says Samad Hussain Patanwala. To provide further insight on his expansion plan, he remarked, “We recognise that the pharmaceutical distributors’ industry plays a critical role in the supply chain of medications from manufacturers to retailers, hospitals, and healthcare institutions. As a result, our goal is to serve as facilitators for the efficient distribution of pharmaceutical items to end users while being cost-effective.”

SAMAD HUSSAIN PATANWALA’S RESPONSE TO HEALTHCARE CHALLENGES

The existence of a growing older population and an increase in the production of generics has led to the expansion of the market. However, customers face a variety of barriers to acquiring medications. The most evident cause of a shortage of medications is the occurrence of global events such as pandemics and natural catastrophes disrupting supply chains and delivery systems. The availability of high-quality counterfeits, which pose a significant danger to the health of customers, is a major issue. Meanwhile, the high cost of pharmaceuticals and poor access in remote areas may make obtaining needed medications difficult. In this new era of pharmaceutical distribution, Den Mark Pharmaceuticals represents a reliable outcome for all of these concerns for consumers.

Samad Hussain Patanwala, assures rapid access to life-saving drugs, antibiotics, and specialised pharmaceuticals owing to his experience and current product inventory. Recognising that the sector is experiencing numerous important changes that are transforming its environment, he has initiated digital transformation by implementing sophisticated technologies such as blockchain and automated supply chain management to improve efficiency and traceability. Taking advantage of expanding worldwide healthcare spending and the growing frequency of chronic conditions, he has not only met drug demand but also demonstrated outstanding resilience, particularly during difficult times.

SAMAD HUSSAIN PATANWALA SHAPING THE FUTURE OF DEN MARK PHARMACEUTICALS

Samad Hussain Patanwala understands that having a constant supply of pharmaceuticals is critical for supporting medical professions and meeting the community’s healthcare demands. Den Mark Pharmaceuticals’ successful distribution network is the result of his tireless efforts. With the help of a dynamic staff, he is implementing a simplified approach that will result in quick shipment and timely fulfilment of orders. This customer-centric strategy has built solid relationships with customers, strengthening their faith in the company’s dependability. At the same time, he emphasises proactive care for his employees, demonstrating the company’s ongoing dedication to employee and customer well-being. Undoubtedly, Samad Hussain Patanwala is a personality who has changed the pharmaceutical field with his never-say-die attitude and strong core principles and ethics, which have helped Den Mark Pharmaceuticals become what it is today!

If you have any objection to this press release content, kindly contact pr.error.rectification@gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.

Mumbai (Maharashtra) [India], June 19: Samad Hussain Patanwala, a passionate and ambitious entrepreneur, has over 9 years of experience in the pharmaceutical sector and intends to bring high-quality and inexpensive pharmaceuticals to overlooked markets worldwide. With a BMS degree in Business Administration and Management and a solid pharmaceutical distribution and marketing foundation, he started Den Mark Pharmaceuticals Pvt. Ltd. in 2021, a pharmaceutical manufacturing and marketing organisation providing EU-grade quality goods to its clients. In keeping with his ideals of innovation, collaboration, and social impact, he aims to foster a diverse and inclusive culture at his firm that empowers and supports his team members.

This article focuses on shedding light on Samad Hussain Patanwala’s roadmap to successful formulations, which he has considered and moulded into his strategy without ever compromising the quality that the client requires. Let’s look at how Den Mark Pharmaceuticals combines cost-effectiveness and quality assurance throughout pharmaceutical manufacturing.

SAMAD HUSSAIN PATANWALA FORGING PONEERING HEALTHCARE SOLUTIONS VIA STRATEGIC LEADERSHIP

Den Mark Pharmaceuticals’ CEO, Samad Hussain Patanwala, leads the company’s strategic direction, operations, and growth. He manages a team of over 50 experts, including scientists, engineers, salesmen, and managers, as well as ties with suppliers, regulators, investors, and business partners. Using his diverse talents in business planning, distribution, and medicines, he has consistently recognised market opportunities, developed products, and enlarged the client base. Under his guidance, the firm launched ten new products, signed several contracts with the government and commercial sector, and boosted revenue by 150% in the last year.

Knowing that the pharmaceutical sector is one of the world’s largest, Samad Hussain Patanwala works tirelessly to produce better pharmaceuticals to battle a variety of ailments. On the other hand, problems and possibilities created by an expanding global population are efficiently paved via additional medicine development required to accommodate for them, ensuring the firm’s overall growth and demonstrating itself as a trustworthy pharmaceutical. Fortunately, Den Mark Pharmaceuticals looks to the growth of scientific knowledge and technology to spur innovation and produce new and more effective treatments.

Samad Hussain Patanwala feels the pharmaceutical business bears a significant obligation to keep the globe healthy. He claims that because the pharmaceutical sector produces, manufactures, and sells pharmaceuticals used to manage medical problems, and prevent, and treat diseases, it has become a more prominent focus for consumers as consumer knowledge has increased. More people want to know if the pharmaceuticals they’re buying are safe to use, if they’re paying the right amount, or if a new drug is about to be introduced that will work better than what’s been used previously. Keeping this in mind, as CEO of Den Mark Pharmaceuticals, he makes a concerted effort to keep the community informed about topics that interest them, including public campaigns and updates on cutting-edge developments. These efforts have increased, improved, and significantly added to his company’s reputation across the world.

DEN MARK PHARMACEUTICAL’S GLOBAL MISSION: QUALITY, ACCESSIBILITY, AND RESPONSIBILITY

Den Mark Pharmaceuticals, with a global reach, has benefited from a global market for its products, owing to its cost-effective budgeting for a diverse clientele. Even patients in impoverished nations, both national and international, have benefited significantly from corporate social responsibility programmes in which Den Mark Pharmaceuticals supplied free medications at reduced costs to patients. In the enormous pharmaceutical sector, every choice is significant. The medications developed can cure, transform lives, and shape the future of healthcare. The procurement process is crucial to this purpose since it involves the sourcing of raw materials, packaging, and completed items. Thus, Samad Hussain Patanwala identifies the essence of the finished product and makes it available to the public at a significantly lower cost.

In a recent conversation, he said, “Imagine a world where discussions are ignored and procurement is all about the bottom line. What was the result? Compromised quality and possible hazards to patient health. The company’s reputation may also suffer. On the other hand, an overemphasis on quality without regard for cost can lead to unsustainable practices, rendering critical treatments unavailable to those who require them the most.”

SAMAD HUSSAIN PATANWALA’S VISION FOR PRESERVING INTEGRITY AND PROMOTING ACCESSIBILITY IN PHARMACEUTICALS

In essence, Samad Hussain Patanwala believes that pharmaceutical procurement involves more than just a contract. It is about protecting the medications’ integrity and ensuring that they reach people in need at a reasonable cost. It’s a job that requires experience, vision, and a thorough awareness of the industry’s complexities.

With Den Mark Pharmaceuticals, he is constructing a bridge that unites cost-effectiveness with the uncompromising standards that the pharmaceutical industry requires. Ensuring that consumers accomplish exceptional quality criteria while saving expenses. It’s a difficult balance to strike, but it’s critical to the industry’s long-term viability and growth.

Negotiation in the pharmaceutical sector involves more than simply achieving the best rates; it is also a delicate art to ensure that cost reductions do not come at the sacrifice of quality. As a result, Denmark has invested in facilities and quality management systems to ensure good manufacturing practice compliance. This investment in quality improvement intervention has proven cost-effective, propelling the company to the top of the manufacturing industry.

If you have any objection to this press release content, kindly contact pr.error.rectification@gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.

The R&D Innovation Lab is dedicated to creating need-based solutions that go beyond existing options, ensuring world-class eye care access for all including the most remote villages in the country

Coimbatore (Tamil Nadu) [India], June 18:  Sankara Eye Foundation, India has launched the country’s first-of-its-kind Innovation Lab supported by G.D. Naidu Charities, focused on advancing eye care through cutting-edge research, development, and training. This center aims to deliver high-quality eye care solutions to underserved populations in India, reaching the most remote rural villages with innovative approaches to diagnosis, treatment, and prevention. 

The centre was inaugurated by Shri. G.D. Gopal, Chairman of G.D. Naidu Charities in the presence of Dr. S.V. Balasubramaniam, Chairman Sankara Eye Foundation, India, Shri. Dr.  R. V. Ramani, Founder- Managing Trustee of Sankara Eye Foundation, India, Mr. Bhaskar Bhat, Director, Tata Sons Private Limited and Trustees & Well Wishers of Sankara Eye Foundation, India. 

Guest of Honor Shri. G.D. Gopal, Chairman, G.D. Naidu Charities said “I am very excited to be a part of this initiative of Sankara Eye Hospital. There is some fantastic work done and it’s great to learn that this is one of its kind unique innovation centres in India and will go on to bring many innovations and establish India in the International Ophthalmology trade section. I wish all the best for the institution.” 

Speaking on the occasion, Dr. Jagadeesh Kumar Reddy, Technical Director & Head of Innovation Lab, Sankara Eye Foundation, India stated, “Our Center for Innovation stands as a testament to our steadfast dedication to enhancing eye care for everyone.  Through a focus on research and development, we strive to bridge healthcare gaps and deliver life-changing solutions to rural and underserved communities in India.” 

“The Research and Development Center will focus on four key domains: the design and development of new devices, digital eye care through AI-enhanced electronic medical records, clinical trials, and comprehensive training programs. This initiative aims to revolutionize eye care by developing advanced digital record systems and AI technologies to improve efficiency, accuracy, and accessibility”. 

“Innovation is at the heart of our efforts. By integrating AI and digital health records into eye care, we are not only enhancing diagnostic accuracy and treatment outcomes but also ensuring that even the most remote communities receive the highest quality of eye care.” 

“The center will also conduct clinical trials approved by CDSCO/DCGI for regulatory compliance, with a dedicated team of clinical research coordinators ensuring adherence to standards. Training programs will feature hands-on sessions, simulation exercises, and virtual reality modules to enhance practical skills for Postgraduate Trainees, Fellows, and Practicing Eye Surgeons.” Dr. Jagadeesh Kumar Reddy, Technical Director of Sankara Eye Hospital quoted.  

Key research areas include the development of new diagnostic tools, surgical instruments, intraocular devices, telemedicine solutions, spectacles, and assistive technologies. The center will explore AI algorithms for medical imaging analysis, improving the detection and classification of common eye conditions such as glaucoma, diabetic retinopathy, and macular degeneration. Additionally, AI will be utilized to create personalized treatment plans based on patient data and predictive analytics. 

The Innovation Lab is equipped with state-of-the-art facilities, including, simulation laboratories, surgical training suites, and a tele-ophthalmology training area. By fostering collaborations with international institutions and industry leaders, the research lab aims to promote global best practices in eye care in our country. 

About Sankara Eye Foundation 

Sankara Eye Foundation India is a Not-for-Profit organisation committed to providing quality eye care services to the poor and marginalised sections of society. Started as a small primary health care centre in the year 1977 by Dr R.V. Ramani and Dr Radha Ramani, today Sankara is one of the largest and fastest growing social enterprises managing 13 super specialty eye care hospitals located across Tamil Nadu, Andhra Pradesh, Karnataka, Gujarat, Punjab, Uttar Pradesh, Madhya Pradesh, Telangana, Rajasthan and Maharashtra.  Our Network Hospitals are equipped with state-of-the-art technology to perform advanced eye surgeries. Sankara Eye Foundation India is a protagonist of the National Eye Health Care Movement in India, continuously transforming the eye care delivery structure through various Eye Care Initiatives across age groups, cutting-edge technology, scientific approach, innovation, research & training. 

For more information about Sankara Eye Foundation, please visit – www.sankaraeye.com

If you have any objection to this press release content, kindly contact pr.error.rectification@gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.

Ahmedabad (Gujarat) [India], June 17: Ahmedabad-based CORONA Remedies, a pharmaceutical company dedicated to promoting good health for all, has set Asia record for screening the highest number of patients for peripheral neuropathy using a biothesiometer in a single week.

Recognised by the Asia Book of Records, this remarkable feat was accomplished from May 5 to 11, 2024 which is observed globally as Neuropathy Awareness Week. The achievement underscores the importance of health awareness and highlights the impact of coordinated health efforts.

A team of CORONA Remedies screened 21,012 patients with the help of 1,231 doctors at neuropathy detection camps across India during the week. The initiative was part of the company’s “Mission Heal India” initiative. It involved collaboration with local healthcare providers, clinics and hospitals, and community leaders in urban centres, rural villages, and remote areas.

Mr. Nirav K. Mehta, Promoter & Executive Director of CORONA Remedies, said, “This record is about raising awareness and providing early diagnoses to thousands who might otherwise suffer in silence. Peripheral neuropathy can significantly impact quality of life. We are dedicated to screening peripheral neuropathy regularly throughout the year, aiming to make more patients about the condition. We aim to make a lasting difference in patients’ lives through ‘Mission Heal India’ with the support of the wider medical fraternity.”

Peripheral neuropathy affects millions globally, especially those with diabetes, endocrine disorders, or vitamin B12 deficiencies. Factors contributing to neuropathy include dietary patterns, particularly vegetarian or vegan diets leading to vitamin B12 and vitamin D deficiencies, heavy alcohol intake, exposure to toxins, side effects of certain drugs, and genetic disorders.

Early detection is crucial for effective management, particularly among diabetic patients as 50% of such patients remain asymptomatic to neuropathy. Without timely intervention, the condition can lead to serious complications like foot ulcers, which can lead to amputations.

Along with raising awareness, this unique initiative has provided valuable epidemiological insights. One notable finding is that the prevalence of severe neuropathy is 2.67 times and moderate neuropathy is 2.56 times higher among diabetic patients compared to others.

The Asia Book of Records, a prominent keeper of records for Asian countries, operates under the World Records Union. It collaborates closely with various national record books, including those in Vietnam, Nepal, Cambodia, India, Indo-China, Bangladesh, the US, Ukraine Book, and Indonesia. Its headquarters are located in India and Vietnam.

CORONA Remedies Private Limited was founded in 2004 with a commitment to ensuring better health for all. CORONA is the youngest and fastest growing amongst the top 40 companies with the 30th Rank in Indian Pharmaceutical Market. CORONA enjoys leadership positions in women’s health, Infertility, and cardiometabolic and a strong presence in Orthopaedics.

CORONA Remedies manufactures a whole gamut of healthcare solutions as per international quality standards in its WHO-GMP/EU GMP-approved plant. CORONA Remedies has 2 DSIR-approved R&D centres with 80+ scientist teams working on novel platform technologies & Hormones. CORONA Remedies is a proud family of 4500+ employees relentlessly working for the common goal of good health for all.

If you have any objection to this press release content, kindly contact pr.error.rectification@gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.

Surat (Gujarat) [India], June 13:  In a first time for Gujarat, a team of American doctors conducted a live training session on APTOS Method, an advanced anti-ageing treatment, for the specialists at Sakhiya Skin Clinic in Surat. The training took place on May 26 at the clinic’s Lal Darwaza location, led by Dr. Lakshyajeet Dhami and Dr. Tornike Aladashvili from Georgia, US. They shared their expertise and provided hands-on training to the clinic’s team.

In today’s fast-paced world, many people struggle to find time for self-care, which is exacerbated by rising air pollution and stress, leading to premature skin ageing. However, awareness about skincare has increased significantly, leading many to undergo various anti-ageing treatments to look younger and prevent ageing. The market for these products has grown fivefold in recent years.

Sakhiya Skin Clinic has been at the forefront of providing advanced anti-ageing treatment services for the past 25 years. It has catered to more than 50,000 people, including many celebrity clients.

Dr. Jagdish Sakhiya, the clinic’s founder, highlighted that people aged 50-60 frequently seek treatments to look and feel younger, and recommended starting such treatments around age 40.

Dr. Sakhiya explained that the APTOS method is a minimally invasive and safe facelift procedure performed using ultra-thin threads. This technique helps correct aesthetic defects on the face and body, smooths wrinkles, and significantly improves skin appearance and structure without surgical intervention. The live training session aimed to help the doctors at Sakhiya Skin Clinic master this innovative method.

The day-long training included both theoretical and practical sessions. Dr. Dhami and Dr. Aladashvili provided in-depth knowledge about the APTOS method, followed by hands-on training to the team. Dr. Sakhiya noted that the live training was highly instructive, equipping the clinic’s doctors with advanced skills to enhance patient care.